American Cancer Society Colorectal Cancer Survivorship Care Guidelines

CA Cancer Journal for Clinicians

Volumn 65, Issue 6, 2015, Pages 427-455

  El Shami, Khaled ^a   Oeffinger, Kevin C ^b   Erb, Nicole L ^c   Willis, Anne ^d   Bretsch, Jennifer K ^e   Pratt Chapman, Mandi L ^d   Cannady, Rachel S ^f   Wong, Sandra L ^g   Rose, Johnie ^h   Barbour, April L ^a   Stein, Kevin D ^f   Sharpe, Katherine B ^f   Brooks, Durado D ^c   Cowens Alvarado, Rebecca L ^c  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c AMERICAN CANCER SOCIETY   (United States)

^d GEORGE WASHINGTON UNIVERSITY   (United States)

^e AMERICAN SOCIETY OF CLINICAL ONCOLOGY   (United States)

^f BEHAVIORAL RESEARCH CENTER   (United States)

^g UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^h CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

care coordination; clinical care; colorectal cancer; follow up; guidelines; late effects; long term effects; primary care; quality of life; survivorship; survivorship care plan

Indexed keywords

ANTIDIARRHEAL AGENT; CAPECITABINE; CARCINOEMBRYONIC ANTIGEN; DULOXETINE; FLUOROURACIL; OXALIPLATIN; PHOSPHODIESTERASE V INHIBITOR; PLACEBO;

ACUTE HEART INFARCTION; AGEUSIA; ANAMNESIS; ANXIETY; ARTICLE; BREAST CANCER; CANCER FATIGUE; CANCER RECURRENCE; CANCER SCREENING; CANCER SURVIVOR; CARDIOTOXICITY; CHRONIC DIARRHEA; CHRONIC PAIN; COGNITIVE DEFECT; COLONOSCOPY; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY DISEASE; DEPRESSION; DISEASE SURVEILLANCE; DISTRESS SYNDROME; EARLY MENOPAUSE; ENDOMETRIUM BIOPSY; ENDOMETRIUM CANCER; ENDOTHELIAL DYSFUNCTION; ERECTILE DYSFUNCTION; FECES INCONTINENCE; FEMALE INFERTILITY; FOLLOW UP; HEALTH PROMOTION; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; LUNG CANCER; MUCOSA INFLAMMATION; NUTRITIONAL HEALTH; OBESITY; OVARY INSUFFICIENCY; PATIENT REFERRAL; PERIPHERAL NEUROPATHY; PERSONALIZED MEDICINE; PHYSICAL ACTIVITY; PHYSICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROCTITIS; PROSTATE CANCER; PSYCHOSOCIAL CARE; QUALITY OF LIFE; RECTUM CANCER; RECTUM HEMORRHAGE; SECOND CANCER; SEXUAL DYSFUNCTION; SMOKING CESSATION; STOMA; THORAX PAIN; TRANSVAGINAL ECHOGRAPHY; URINE INCONTINENCE; URINE RETENTION; UTERINE CERVIX CANCER; XEROSTOMIA; AFTERCARE; COLORECTAL NEOPLASMS; COMPLICATION; EARLY CANCER DIAGNOSIS; FEMALE; INTERDISCIPLINARY COMMUNICATION; MALE; NEOPLASMS, SECOND PRIMARY; PATIENT CARE; PRACTICE GUIDELINE; PRIMARY HEALTH CARE; PROCEDURES; PSYCHOLOGY; SURVIVOR; TUMOR RECURRENCE;

AFTERCARE; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HEALTH PROMOTION; HUMANS; INTERDISCIPLINARY COMMUNICATION; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, SECOND PRIMARY; PATIENT CARE TEAM; PRIMARY HEALTH CARE; QUALITY OF LIFE; SURVIVORS;

EID: 84947046602     PISSN: 00079235     EISSN: 15424863     Source Type: Journal    
DOI: 10.3322/caac.21286     Document Type: Article

References (154)

1. Institute of Medicine. From Cancer Patient to Cancer Survivor: Lost in Transition. Washington, DC: The National Academies Press; 2005. Accessed April 29, 2015.
2. Reugen SH,; for The President's Cancer Panel. Living Beyond Cancer: Finding a New Balance. President's Cancer Panel 2003-2004 Annual Report. Bethesda, MD: National Cancer Institute, National Institutes of Health, US Department of Health and Human Services; 2004. deainfo.nci.nih.gov/advisory/pcp/annualReports/pcp03-04rpt/Survivorship.pdf. Accessed April 29, 2015.
3. Centers for Disease Control and Prevention. A National Action Plan for Cancer Survivorship: Advancing Public Health Strategies. Atlanta, GA: Centers for Disease Control and Prevention, Lance Armstrong Foundation; 2004.
4. Institute of Medicine. Cancer Care for the Whole Patient: Meeting Psychosocial Health Needs. Washington, DC: The National Academies Press; 2007.
5. Mullan F,. Seasons of survival: reflections of a physician with cancer. N Engl J Med. 1985; 313: 270-273.
6. McCabe MS, Bhatia S, Oeffinger KC, et al., American Society of Clinical Oncology statement: achieving high-quality cancer survivorship care. J Clin Oncol. 2013; 31: 631-640.
7. ®) Colon Cancer Version 2.2015. © 2015 National Comprehensive Cancer Network, Inc. Available at NCCN.org. Accessed April 29, 2015.
8. ®) Rectal Cancer Version 2.2015. © 2015 National Comprehensive Cancer Network, Inc. Available at NCCN.org. Accessed April 29, 2015.
9. ®) Survivorship Version 2.2015. © 2015 National Comprehensive Cancer Network, Inc. Available at NCCN.org. Accessed April 29, 2015.
10. Bower JE, Bak K, Berger A, et al., Screening, assessment, and management of fatigue in adult survivors of cancer: an American Society of Clinical oncology clinical practice guideline adaptation. J Clin Oncol 10 32: 1840-1850, 2014.
11. Andersen BL, DeRubeis RJ, Berman BS, et al., Screening, assessment, and care of anxiety and depressive symptoms in adults with cancer: an American Society of Clinical Oncology guideline adaptation. J Clin Oncol. 2014; 32: 1605-1619.
12. Hershman DL, Lacchetti C, Dworkin RH, et al., Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 2014; 32: 1941-1967.
13. Loren AW, Mangu PB, Beck LN, et al., Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013; 31: 2500-2510.
14. Smith TJ, Temin S, Alesi ER, et al., American Society of Clinical Oncology provisional clinical opinion: the integration of palliative care into standard oncology care. J Clin Oncol. 2012; 30: 880-887.
15. Cowens-Alvarado R, Sharpe K, Pratt-Chapman M, et al., Advancing survivorship care through the National Cancer Survivorship Resource Center: developing American Cancer Society guidelines for primary care providers. CA Cancer J Clin. 2013; 63: 147-150.
16. Siegel RL, Miller KD, Jemal A,. Cancer statistics, 2015. CA Cancer J Clin. 2015; 65: 5-29.
17. Howlader N, Noone AM, Krapcho M, et al. eds. SEER Cancer Statistics Review 1975-2012. Bethesda, MD: National Cancer Institute; based on November 2014 SEER data submission, posted to the SEER website April 2015. seer.cancer.gov/csr/1975-2012/browse-csr.php?sectionSEL=1&page SEL=sect-01-table.23.html.
18. Siegel R, Desantis C, Jemal A,. Colorectal cancer statistics, 2014. CA Cancer J Clin. 2014; 64: 104-117.
19. DeSantis CE, Lin CC, Mariotto AB, et al., Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin. 2014; 64: 252-271.
20. Miller K, ed. Excellent Care for Cancer Survivors: A Guide to Fully Meet Their Needs in Medical Offices and in the Community. Santa Barbara, CA: Praeger; 2011.
21. Skolarus TA, Wolf AM, Erb NL, et al., American Cancer Society prostate cancer survivorship care guidelines. CA Cancer J Clin. 2014; 64: 225-249.
22. Brawley O, Byers T, Chen A, et al., New American Cancer Society process for creating trustworthy cancer screening guidelines. JAMA. 2011; 306: 2495-2499.
23. Institute of Medicine. Clinical Practice Guidelines We Can Trust. Washington, DC: The National Academies Press; 2011.
24. Meyerhardt JA, Mangu PB, Flynn PJ, et al., Follow-up care, surveillance protocol, and secondary prevention measures for survivors of colorectal cancer: American Society of Clinical Oncology clinical practice guideline endorsement. J Clin Oncol. 2013; 31: 4465-4470.
25. Rose J, Augestad KM, Cooper GS,. Colorectal cancer surveillance: what's new and what's next. World J Gastroenterol. 2014; 20: 1887-1897.
26. Sargent DJ, Patiyil S, Yothers G, et al., End points for colon cancer adjuvant trials: observations and recommendations based on individual patient data from 20,898 patients enrolled onto 18 randomized trials from the ACCENT Group. J Clin Oncol. 2007; 25: 4569-4574.
27. Smith RA, Manassaram-Baptiste D, Brooks D, et al., Cancer screening in the United States, 2015: a review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin. 2015; 65: 30-54.
28. Smith RA, Saslow D, Sawyer KA, et al., American Cancer Society guidelines for breast cancer screening: update 2003. CA Cancer J Clin. 2003; 53: 141-169.
29. Wolf AM, Wender RC, Etzioni RB, et al., American Cancer Society guideline for the early detection of prostate cancer: update 2010. CA Cancer J Clin. 2010; 60: 70-98.
30. Koornstra JJ, Mourits MJ, Sijmons RH, Leliveld AM, Hollema H, Kleibeuker JH,. Management of extracolonic tumours in patients with Lynch syndrome. Lancet Oncol. 2009; 10: 400-408.
31. Barrow E, Robinson L, Alduaij W, et al., Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: a report of 121 families with proven mutations. Clin Genet. 2009; 75: 141-149.
32. Dijkhuizen FP, Mol BW, Brolmann HA, Heintz AP,. The accuracy of endometrial sampling in the diagnosis of patients with endometrial carcinoma and hyperplasia: a meta-analysis. Cancer. 2000; 89: 1765-1772.
33. Breijer MC, Peeters JA, Opmeer BC, et al., Capacity of endometrial thickness measurement to diagnose endometrial carcinoma in asymptomatic postmenopausal women: a systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2012; 40: 621-629.
34. Schmeler KM, Lynch HT, Chen LM, et al., Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome. N Engl J Med. 2006; 354: 261-269.
35. Lindor NM, Petersen GM, Hadley DW, et al., Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. JAMA. 2006; 296: 1507-1517.
36. Ramsey SD, Berry K, Moinpour C, Giedzinska A, Andersen MR,. Quality of life in long term survivors of colorectal cancer. Am J Gastroenterol. 2002; 97: 1228-1234.
37. Emmertsen KJ, Laurberg S,; Rectal Cancer Function Study Group. Impact of bowel dysfunction on quality of life after sphincter-preserving resection for rectal cancer. Br J Surg. 2013; 100: 1377-1387.
38. Guren MG, Eriksen MT, Wiig JN, et al., Quality of life and functional outcome following anterior or abdominoperineal resection for rectal cancer. Eur J Surg Oncol. 2005; 31: 735-742.
39. Braendengen M, Tveit KM, Bruheim K, Cvancarova M, Berglund A, Glimelius B,. Late patient-reported toxicity after preoperative radiotherapy or chemoradiotherapy in nonresectable rectal cancer: results from a randomized phase III study. Int J Radiat Oncol Biol Phys. 2011; 81: 1017-1024.
40. Lange MM, Martz JE, Ramdeen B, et al., Long-term results of rectal cancer surgery with a systematical operative approach. Ann Surg Oncol. 2013; 20: 1806-1815.
41. Peeters KC, van de Velde CJ, Leer JW, et al., Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients-a Dutch Colorectal Cancer Group study. J Clin Oncol. 2005; 23: 6199-6206.
42. Gami B, Harrington K, Blake P, et al., How patients manage gastrointestinal symptoms after pelvic radiotherapy. Aliment Pharmacol Ther. 2003; 18: 987-994.
43. Khan NF, Mant D, Carpenter L, Forman D, Rose PW,. Long-term health outcomes in a British cohort of breast, colorectal and prostate cancer survivors: a database study. Br J Cancer. 2011; 105 (suppl 1): S29-S37.
44. Jensen SA, Sorensen JB,. 5-fluorouracil-based therapy induces endovascular injury having potential significance to development of clinically overt cardiotoxicity. Cancer Chemother Pharmacol. 2012; 69: 57-64.
45. Polk A, Vistisen K, Vaage-Nilsen M, Nielsen DL,. A systematic review of the pathophysiology of 5-fluorouracil-induced cardiotoxicity [serial online]. BMC Pharmacol Toxicol. 2014; 15: 47.
46. Polk A, Vaage-Nilsen M, Vistisen K, Nielsen DL,. Cardiotoxicity in cancer patients treated with 5-fluorouracil or capecitabine: a systematic review of incidence, manifestations and predisposing factors. Cancer Treat Rev. 2013; 39: 974-984.
47. Martinez ME, Giovannucci E, Spiegelman D, Hunter DJ, Willett WC, Colditz GA,. Leisure-time physical activity, body size, and colon cancer in women. Nurses' Health Study Research Group. J Natl Cancer Inst. 1997; 89: 948-955.
48. Giovannucci E, Ascherio A, Rimm EB, Colditz GA, Stampfer MJ, Willett WC,. Physical activity, obesity, and risk for colon cancer and adenoma in men. Ann Intern Med. 1995; 122: 327-334.
49. Hawkes AL, Lynch BM, Owen N, Aitken JF,. Lifestyle factors associated concurrently and prospectively with comorbid cardiovascular disease in a population-based cohort of colorectal cancer survivors. Eur J Cancer. 2011; 47: 267-276.
50. Cramer H, Lauche R, Klose P, Dobos G, Langhorst J,. A systematic review and meta-analysis of exercise interventions for colorectal cancer patients. Eur J Cancer Care (Engl). 2014; 23: 3-14.
51. Jones LW, Haykowsky MJ, Swartz JJ, Douglas PS, Mackey JR,. Early breast cancer therapy and cardiovascular injury. J Am Coll Cardiol. 2007; 50: 1435-1441.
52. Wefel JS, Kesler SR, Noll KR, Schagen SB,. Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adults. CA Cancer J Clin. 2015; 65: 123-138.
53. Jean-Pierre P, Winters PC, Ahles TA, et al., Prevalence of self-reported memory problems in adult cancer survivors: a national cross-sectional study. J Clin Oncol. 2012; 8: 30-34.
54. Jansen L, Hoffmeister M, Chang-Claude J, Koch M, Brenner H, Arndt V,. Age-specific administration of chemotherapy and long-term quality of life in stage II and III colorectal cancer patients: a population-based prospective cohort. Oncologist. 2011; 16: 1741-1751.
55. Tannock IF, Ahles TA, Ganz PA, Van Dam FS,. Cognitive impairment associated with chemotherapy for cancer: report of a workshop. J Clin Oncol. 2004; 22: 2233-2239.
56. Simard S, Thewes B, Humphris G, et al., Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies. J Cancer Surviv. 2013; 7: 300-322.
57. Boyes AW, Girgis A, Zucca AC, Lecathelinais C,. Anxiety and depression among long-term survivors of cancer in Australia: results of a population-based survey [comment]. Med J Aust. 2009; 191: 295.
58. Hoffman KE, McCarthy EP, Recklitis CJ, Ng AK,. Psychological distress in long-term survivors of adult-onset cancer: results from a national survey. Arch Int Med. 2009; 169: 1274-1281.
59. Mitchell AJ, Ferguson DW, Gill J, Paul J, Symonds P,. Depression and anxiety in long-term cancer survivors compared with spouses and healthy controls: a systematic review and meta-analysis. Lancet Oncol. 2013; 14: 721-732.
60. Denlinger CS, Barsevick AM,. The challenges of colorectal cancer survivorship. J Natl Compr Cancer Netw. 2009; 7: 883-893; quiz 894.
61. Ross L, Abild-Nielsen AG, Thomsen BL, Karlsen RV, Boesen EH, Johansen C,. Quality of life of Danish colorectal cancer patients with and without a stoma. Support Care Cancer. 2007; 15: 505-513.
62. ®) Distress Management Version 1.2015. © 2015 National Comprehensive Cancer Network, Inc. Available at NCCN.org. Accessed June 16, 2015.
63. Patel D, Sharpe L, Thewes B, Bell ML, Clarke S,. Using the Distress Thermometer and Hospital Anxiety and Depression Scale to screen for psychosocial morbidity in patients diagnosed with colorectal cancer. J Affect Disord. 2011; 131 (1-3): 412-416.
64. Campbell HS, Sanson-Fisher R, Turner D, Hayward L, Wang XS, Taylor-Brown J,. Psychometric properties of cancer survivors' unmet needs survey. Support Care Cancer. 2010; 19: 221-230.
65. Campbell HS, Hall AE, Sanson-Fisher RW, Barker D, Turner D, Taylor-Brown J,. Development and validation of the Short-Form Survivor Unmet Needs Survey (SF-SUNS). Support Care Cancer. 2014; 22: 1071-1079.
66. Mayo Clinic. Diseases and Conditions: Depression (major depressive disorder). Diseases and Conditions. Rochester, MN: Mayo Foundation for Medical Education and Research; 2014. mayoclinic.org/diseases-conditions/depression/basics/definition/con-20032977. Accessed November 7, 2014.
67. Mayo Clinic. Diseases and Conditions: Anxiety. Rochester, MN: Mayo Foundation for Medical Education and Research; 2014. mayoclinic.org/diseases-conditions/anxiety/basics/definition/con-20026282. Accessed November 7, 2014.
68. Medeiros M, Oshima CT, Forones NM,. Depression and anxiety in colorectal cancer patients. J Gastrointest Cancer. 2010; 41: 179-184.
69. Zigmond AS, Snaith RP,. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983; 67: 361-370.
70. Lewinsohn PM, Seeley JR, Roberts RE, Allen NB,. Center for Epidemiologic Studies Depression Scale (CES-D) as a screening instrument for depression among community-residing older adults. Psychol Aging. 1997; 12: 277-287.
71. Radloff LS,. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977; 1: 385-401.
72. Krebber AM, Buffart LM, Kleijn G, et al., Prevalence of depression in cancer patients: a meta-analysis of diagnostic interviews and self-report instruments. Psychooncology. 2014; 23: 121-130.
73. Kuchler T, Bestmann B, Rappat S, Henne-Bruns D, Wood-Dauphinee S,. Impact of psychotherapeutic support for patients with gastrointestinal cancer undergoing surgery: 10-year survival results of a randomized trial. J Clin Oncol. 2007; 25: 2702-2708.
74. Sharma A, Walker LG, Monson JR,. Baseline quality of life factors predict long term survival after elective resection for colorectal cancer. Int J Surg Oncol 2013: 269510-269510, 2013.
75. Mishra SI SR, Geigle PM, et al., Exercise interventions on health-related quality of life for cancer survivors [serial online]. Cochrane Database Syst Rev. 2012; 8: CD007566.
76. ®) Cancer-Related Fatigue Version 2.2015. © 2015 National Comprehensive Cancer Network, Inc. Available at NCCN.org. Accessed April 29, 2015.
77. Wang XS, Zhao F, Fisch MJ, et al., Prevalence and characteristics of moderate to severe fatigue: a multicenter study in cancer patients and survivors. Cancer. 2014; 120: 425-432.
78. Yanez B, Pearman T, Lis CG, Beaumont JL, Cella D,. The FACT-G7: a rapid version of the Functional Assessment of Cancer Therapy-General (FACT-G) for monitoring symptoms and concerns in oncology practice and research. Ann Oncol. 2013; 24: 1073-1078.
79. Wang XS, Cleeland CS, Mendoza TR, et al., Impact of cultural and linguistic factors on symptom reporting by patients with cancer. J Natl Cancer Inst. 2010; 102: 732-738.
80. Minton O, Strasser F, Radbruch L, Stone P,. Identification of factors associated with fatigue in advanced cancer: a subset analysis of the European palliative care research collaborative computerized symptom assessment data set. J Pain Symptom Manage. 2012; 43: 226-235.
81. Kuhnt S, Ernst J, Singer S, et al., Fatigue in cancer survivors-prevalence and correlates. Onkologie. 2009; 32: 312-317.
82. Mendoza TR, Wang XS, Cleeland CS, et al., The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory. Cancer. 1999; 85: 1186-1196.
83. Servaes P, Gielissen MF, Verhagen S, Bleijenberg G,. The course of severe fatigue in disease-free breast cancer patients: a longitudinal study. Psychooncology. 2007; 16: 787-795.
84. Pachman DR, Barton DL, Swetz KM, Loprinzi CL,. Troublesome symptoms in cancer survivors: fatigue, insomnia, neuropathy, and pain. J Clin Oncol. 2012; 30: 3687-3696.
85. Mitchell SA,. Cancer-related fatigue: state of the science. PM R. 2010; 2: 364-383.
86. Mitchell SA, Beck SL, Hood LE, Moore K, Tanner ER,. Putting evidence into practice: evidence-based interventions for fatigue during and following cancer and its treatment. Clin J Oncol Nurs. 2007; 11: 99-113.
87. Howell D, Keller-Olaman S, Oliver TK, et al., A pan-Canadian practice guideline and algorithm: screening, assessment, and supportive care of adults with cancer-related fatigue [serial online]. Curr Oncol. 2013; 20: e233-e246.
88. Butt Z, Wagner LI, Beaumont JL, et al., Use of a single-item screening tool to detect clinically significant fatigue, pain, distress, and anorexia in ambulatory cancer practice. J Pain Symptom Manage. 2008; 35: 20-30.
89. Cleeland CS, Mendoza TR, Wang XS, et al., Assessing symptom distress in cancer patients: the MD Anderson Symptom Inventory. Cancer. 2000; 89: 1634-1646.
90. Janjan NA, Wang XS, Mendoza T, et al., Utility of the MD Anderson Symptom Assessment Inventory (MDASI) for symptom evaluation during chemoradiation in patients with gastrointestinal malignancies [abstract]. J Clin Oncol. 2007; 25 (18S). Abstract 6613.
91. Cella DF, Tulsky DS, Gray G, et al., The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol. 1993; 11: 570-579.
92. Hann DM, Jacobsen PB, Azzarello LM, et al., Measurement of fatigue in cancer patients: development and validation of the Fatigue Symptom Inventory. Qual Life Res. 1998; 7: 301-310.
93. Stein KD, Martin SC, Hann DM, Jacobsen PB,. A multidimensional measure of fatigue for use with cancer patients. Cancer Pract. 1998; 6: 143-152.
94. Chambers SK, Meng X, Youl P, Aitken J, Dunn J, Baade P,. A five-year prospective study of quality of life after colorectal cancer. Qual Life Res. 2012; 21: 1551-1564.
95. Klika RJ, Callahan KE, Drum SN,. Individualized 12-week exercise training programs enhance aerobic capacity of cancer survivors. Phys Sportsmed. 2009; 37: 68-77.
96. Spence RR, Heesch KC, Brown WJ,. Exercise and cancer rehabilitation: a systematic review. Cancer Treat Rev. 2010; 36: 185-194.
97. Speed-Andrews AE, Courneya KS,. Effects of exercise on quality of life and prognosis in cancer survivors. Curr Sports Med Rep. 2009; 8: 176-181.
98. Wolf S, Barton D, Kottschade L, Grothey A, Loprinzi C,. Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies. Eur J Cancer. 2008; 44: 1507-1515.
99. Beijers AJ, Mols F, Vreugdenhil G,. A systematic review on chronic oxaliplatin-induced peripheral neuropathy and the relation with oxaliplatin administration. Support Care Cancer. 2014; 22: 1999-2007.
100. Krishnan AV, Goldstein D, Friedlander M, Kiernan MC,. Oxaliplatin-induced neurotoxicity and the development of neuropathy. Muscle Nerve. 2005; 32: 51-60.
101. Ocean AJ, Vahdat LT,. Chemotherapy-induced peripheral neuropathy: pathogenesis and emerging therapies. Support Care Cancer. 2004; 12: 619-625.
102. Quasthoff S, Hartung HP,. Chemotherapy-induced peripheral neuropathy. J Neurol. 2002; 249: 9-17.
103. Mols F, Beijers T, Lemmens V, van den Hurk CJ, Vreugdenhil G, van de Poll-Franse LV,. Chemotherapy-induced neuropathy and its association with quality of life among 2- to 11-year colorectal cancer survivors: results from the population-based PROFILES registry. J Clin Oncol. 2013; 31: 2699-2707.
104. Grothey A,. Oxaliplatin-safety profile: neurotoxicity. Semin Oncol Nurs. 2003; 30 (4 suppl 15): 5-13.
105. Argyriou AA, Bruna J, Marmiroli P, Cavaletti G,. Chemotherapy-induced peripheral neurotoxicity (CIPN): an update. Crit Rev Oral Biol. 2012; 82: 51-77.
106. Hausheer FH, Schilsky RL, Bain S, Berghorn EJ, Lieberman F,. Diagnosis, management, and evaluation of chemotherapy-induced peripheral neuropathy. Semin Oncol Nurs. 2006; 33: 15-49.
107. Park SB, Goldstein D, Krishnan AV, et al., Chemotherapy-induced peripheral neurotoxicity: a critical analysis. CA Cancer J Clin. 2013; 63: 419-437.
108. US National Institutes of Health, National Cancer Institute, National Cancer Therapy Evaluation Program. Common Terminology Criteria for Adverse Events (CTCAE) Version 4.03. Bethesda, MD: National Cancer Institute, Cancer Therapy Evaluation Program; 2010.
109. Brouwers EE, Huitema AD, Boogerd W, Beijnen JH, Schellens JH,. Persistent neuropathy after treatment with cisplatin and oxaliplatin. Acta Oncol. 2009; 48: 832-841.
110. Vatandoust S, Joshi R, Pittman KB, et al., A descriptive study of persistent oxaliplatin-induced peripheral neuropathy in patients with colorectal cancer. Support Care Cancer. 2014; 22: 513-518.
111. Land SR, Kopec JA, Cecchini RS, et al., Neurotoxicity from oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: NSABP C-07. J Clin Oncol. 2007; 25: 2205-2211.
112. Smith EM, Pang H, Cirrincione C, et al., Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial. JAMA. 2013; 309: 1359-1367.
113. Choi M, Craft B, Geraci SA,. Surveillance and monitoring of adult cancer survivors. Am J Med. 2011; 124: 598-601.
114. Liu L, Herrinton LJ, Hornbrook MC, et al., Early and late complications among long-term colorectal cancer survivors with ostomy or anastomosis. Dis Colon Rectum. 2010; 53: 200-212.
115. Danielsen AK, Burcharth J, Rosenberg J,. Patient education has a positive effect in patients with a stoma: a systematic review [serial online]. Colorectal Dis. 2013; 15: e276-e283.
116. Schmidt-Hansen M, Bennett MI, Arnold S, Bromham N, Hilgart JS,. Oxycodone for cancer-related pain [serial online]. Cochrane Database Syst Rev. 2015; 2: CD003870.
117. Negrini S, Imperio G, Villafane JH, Negrini F, Zaina F,. Systematic reviews of physical and rehabilitation medicine Cochrane contents. Part 1. Disabilities due to spinal disorders and pain syndromes in adults. Eur J Phys Rehab Med. 2013; 49: 597-609.
118. Parry C, Kent EE, Mariotto AB, Alfano CM, Rowland JH,. Cancer survivors: a booming population. Cancer Epidemiol Biomarkers Prev. 2011; 20: 1996-2005.
119. National Cancer Institute, Surveillance, Epidemiology, and End Results (SEER) Program. Table 1.23: US complete prevalence counts, invasive cancers only, January 1, 2012, by age at prevalence. In:, Howlader N, Noone AM, Krapcho M, et al, eds. SEER Cancer Statistics Review 1975-2011. Bethesda, MD: National Cancer Institute; based on November 2013 SEER data submission, posted to the SEER website April 2014. seer.cancer.gov/csr/1975-2012 /. Accessed February 4, 2015.
120. Spanos CP, Mamopoulos A, Tsapas A, Syrakos T, Kiskinis D,. Female fertility and colorectal cancer. Int J Colorectal Dis. 2008; 23: 735-743.
121. Elizur SE, Tulandi T, Meterissian S, Huang JY, Levin D, Tan SL,. Fertility preservation for young women with rectal cancer-a combined approach from one referral center. J Gastrointest Surg. 2009; 13: 1111-1115.
122. Hermann RM, Henkel K, Christiansen H, et al., Testicular dose and hormonal changes after radiotherapy of rectal cancer. Radiother Oncol. 2005; 75: 83-88.
123. Cercek A, Siegel CL, Capanu M, Reidy-Lagunes D, Saltz LB,. Incidence of chemotherapy-induced amenorrhea in premenopausal women treated with adjuvant FOLFOX for colorectal cancer. Clin Colorectal Cancer. 2013; 12: 163-167.
124. Ho VP, Lee Y, Stein SL, Temple LK,. Sexual function after treatment for rectal cancer: a review. Dis Colon Rectum. 2011; 54: 113-125.
125. Donovan KA, Thompson LM, Hoffe SE,. Sexual function in colorectal cancer survivors. Cancer Control. 2010; 17: 44-51.
126. Downing A, Morris EJ, Richards M, et al., Health-related quality of life after colorectal cancer in England: a patient-reported outcomes study of individuals 12 to 36 months after diagnosis. J Clin Oncol. 2015; 33: 616-624.
127. Den Oudsten BL, Traa MJ, Thong MS, et al., Higher prevalence of sexual dysfunction in colon and rectal cancer survivors compared with the normative population: a population-based study. Eur J Cancer. 2012; 48: 3161-3170.
128. Lange MM, Marijnen CA, Maas CP, et al., Risk factors for sexual dysfunction after rectal cancer treatment. Eur J Cancer. 2009; 45: 1578-1588.
129. Philip EJ, Nelson C, Temple L, et al., Psychological correlates of sexual dysfunction in female rectal and anal cancer survivors: analysis of baseline intervention data. J Sex Med. 2013; 10: 2539-2548.
130. Traa MJ, Orsini RG, Den Oudsten BL, et al., Measuring the health-related quality of life and sexual functioning of patients with rectal cancer: does type of treatment matter? Int J Cancer. 2014; 134: 979-987.
131. Ball M, Nelson CJ, Shuk E, et al., Men's experience with sexual dysfunction post-rectal cancer treatment: a qualitative study. J Cancer Educ. 2013; 28: 494-502.
132. Carter J, Stabile C, Seidel B, et al., Baseline characteristics and concerns of female cancer patients/survivors seeking treatment at a Female Sexual Medicine Program [published online ahead of print January 8, 2015]. Support Care Cancer. 2015. doi: 10.1007/s00520.
133. Park SY, Choi GS, Park JS, Kim HJ, Park JA, Choi JI,. Efficacy and safety of udenafil for the treatment of erectile dysfunction after total mesorectal excision of rectal cancer: a randomized, double-blind, placebo-controlled trial. Surgery. 2015; 157: 64-71.
134. Sturdee DW, Panay N,; International Menopause Society Writing Group. Recommendations for the management of postmenopausal vaginal atrophy. Climacteric. 2010; 13: 509-522.
135. Averyt JC, Nishimoto PW,. Addressing sexual dysfunction in colorectal cancer survivorship care. J Gastrointest Oncol. 2014; 5: 388-394.
136. Korolija D, Sauerland S, Wood-Dauphinee S, et al., Evaluation of quality of life after laparoscopic surgery: evidence-based guidelines of the European Association for Endoscopic Surgery. Surg Endosc. 2004; 18: 879-897.
137. Delacroix SE Jr, Winters JC,. Voiding dysfunction after pelvic colorectal surgery. Clin Colon Rectal Surg. 2010; 23: 119-127.
138. Panjari M, Bell RJ, Burney S, Bell S, McMurrick PJ, Davis SR,. Sexual function, incontinence, and wellbeing in women after rectal cancer-a review of the evidence. J Sex Med. 2012; 9: 2749-2758.
139. Lange MM, van de Velde CJ,. Faecal and urinary incontinence after multimodality treatment of rectal cancer [serial online]. PLoS Med. 2008; 5: e202.
140. Rock CL, Doyle C, Demark-Wahnefried W, et al., Nutrition and physical activity guidelines for cancer survivors. CA Cancer J Clin. 2012; 62: 243-274.
141. Sinicrope FA, Foster NR, Yothers G, et al., Body mass index at diagnosis and survival among colon cancer patients enrolled in clinical trials of adjuvant chemotherapy. Cancer. 2013; 119: 1528-1536.
142. Gibson TM, Park Y, Robien K, et al., Body mass index and risk of second obesity-associated cancers after colorectal cancer: a pooled analysis of prospective cohort studies. J Clin Oncol. 2014; 32: 4004-4011.
143. Dignam JJ, Polite BN, Yothers G, et al., Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer. J Natl Cancer Inst. 2006; 98: 1647-1654.
144. Meyerhardt JA, Niedzwiecki D, Hollis D, et al., Impact of body mass index and weight change after treatment on cancer recurrence and survival in patients with stage III colon cancer: findings from Cancer and Leukemia Group B 89803. J Clin Oncol. 2008; 26: 4109-4115.
145. Schmid D, Leitzmann MF,. Association between physical activity and mortality among breast cancer and colorectal cancer survivors: a systematic review and meta-analysis. Ann Oncol. 2014; 25: 1293-1311.
146. Meyerhardt JA, Sato K, Niedzwiecki D, et al., Dietary glycemic load and cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803. J Natl Cancer Inst. 2012; 104: 1702-1711.
147. Meyerhardt JA, Niedzwiecki D, Hollis D, et al., Association of dietary patterns with cancer recurrence and survival in patients with stage III colon cancer. JAMA. 2007; 298: 754-764.
148. US Department of Health & Human Services, National Institutes of Health, Office of Dietary Supplements. Vitamin D. Fact Sheet for Health Professionals. Bethesda, MD: National Institutes of Health, Office of Dietary Supplements; 2014. ods.od.nih.gov/factsheets/list-all/VitaminD-HealthProfessional/. Accessed April 29, 2015.
149. US Department of Health & Human Services, National Institutes of Health, Office of Dietary Supplements. Calcium. Dietary suppl Fact Sheet. Bethesda, MD: National Institutes of Health, Office of Dietary Supplements; 2013. ods.od.nih.gov/factsheets/Calcium-HealthProfessional/. Accessed April 29, 2015.
150. Yang B, Jacobs EJ, Gapstur SM, Stevens V, Campbell PT,. Active smoking and mortality among colorectal cancer survivors: the Cancer Prevention Study II nutrition cohort. J Clin Oncol. 2015; 33: 885-893.
151. Zhu Y, Yang SR, Wang PP, et al., Influence of pre-diagnostic cigarette smoking on colorectal cancer survival: overall and by tumour molecular phenotype. Br J Cancer. 2014; 110: 1359-1366.
152. Westmaas JL, Alcaraz KI, Berg CJ, Stein KD,. Prevalence and correlates of smoking and cessation-related behavior among survivors of ten cancers: findings from a nationwide survey nine years after diagnosis. Cancer Epidemiol Biomarkers Prev. 2014; 23: 1783-1792.
153. Mayer DK, Birken SA, Check DK, Chen RC,. Summing it up: an integrative review of studies of cancer survivorship care plans (2006-2013). Cancer. 2015; 121: 978-996.
154. Brennan ME, Gormally JF, Butow P, Boyle FM, Spillane AJ,. Survivorship care plans in cancer: a systematic review of care plan outcomes. Br J Cancer. 2014; 111: 1899-1908.